FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2337290468> ?p ?o ?g. }

• W2337290468 endingPage "459" @default.
• W2337290468 startingPage "453" @default.
• W2337290468 abstract "Although methods of viral attenuation in plasma-derived clotting-factor concentrates have improved, there is still a possibility that such concentrates may transmit certain blood-borne viruses. For this reason, the use of recombinant DNA-derived factor VIII (which is virus-free) to treat hemophilia A has generated considerable interest.We conducted a multicenter trial in previously untreated children with hemophilia A. They received recombinant factor VIII for all treatment or for prophylaxis and were evaluated at their respective clinics at intervals of no more than three months.Between January 1, 1989, and July 1, 1992, 95 patients who could be evaluated received recombinant factor VIII. By September 1, 1992, they had received the concentrate exclusively for 2.4 months to 3.5 years (median, 1.5 years). All responded well, with no treatment failures. A total of 3315 infusions were administered; there were three reports of minor adverse reactions. Inhibitor antibodies to factor VIII developed in 16 of 81 patients tested for them, after a median of nine days of exposure to factor VIII treatment. Inhibitor titers were or became low in 9 of the 16 patients despite continued episodic treatment with the concentrate. Inhibitors disappeared completely in 4 patients and remained at a low level (< 10 Bethesda units) in 5 patients receiving episodic treatment.Transient or low levels of inhibitor, as observed in this study, may represent part of the natural history of hemophilia in infants. In view of the transient nature and lower concentration of the inhibitors detected and the generally satisfactory response to treatment, the benefits of recombinant factor VIII for the treatment of hemophilia seem to outweigh the risks." @default.
• W2337290468 created "2016-06-24" @default.
• W2337290468 creator A5049615226 @default.
• W2337290468 creator A5056108298 @default.
• W2337290468 creator A5059475095 @default.
• W2337290468 creator A5080954009 @default.
• W2337290468 date "1993-02-18" @default.
• W2337290468 modified "2023-10-17" @default.
• W2337290468 title "Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors" @default.
• W2337290468 cites W1537744156 @default.
• W2337290468 cites W1870852515 @default.
• W2337290468 cites W1968080067 @default.
• W2337290468 cites W1984899084 @default.
• W2337290468 cites W1987088922 @default.
• W2337290468 cites W1998614164 @default.
• W2337290468 cites W2007261550 @default.
• W2337290468 cites W2013440074 @default.
• W2337290468 cites W2042508808 @default.
• W2337290468 cites W2042833105 @default.
• W2337290468 cites W2057770899 @default.
• W2337290468 cites W2078561615 @default.
• W2337290468 cites W2112144346 @default.
• W2337290468 cites W2152128942 @default.
• W2337290468 cites W2324395680 @default.
• W2337290468 cites W2337912069 @default.
• W2337290468 cites W2402476402 @default.
• W2337290468 cites W2403232606 @default.
• W2337290468 cites W2406041255 @default.
• W2337290468 cites W2415065454 @default.
• W2337290468 cites W3041047318 @default.
• W2337290468 cites W4249121044 @default.
• W2337290468 cites W4252684946 @default.
• W2337290468 cites W55755498 @default.
• W2337290468 cites W91916387 @default.
• W2337290468 doi "https://doi.org/10.1056/nejm199302183280701" @default.
• W2337290468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8421474" @default.
• W2337290468 hasPublicationYear "1993" @default.
• W2337290468 type Work @default.
• W2337290468 sameAs 2337290468 @default.
• W2337290468 citedByCount "461" @default.
• W2337290468 countsByYear W23372904682012 @default.
• W2337290468 countsByYear W23372904682013 @default.
• W2337290468 countsByYear W23372904682014 @default.
• W2337290468 countsByYear W23372904682015 @default.
• W2337290468 countsByYear W23372904682016 @default.
• W2337290468 countsByYear W23372904682017 @default.
• W2337290468 countsByYear W23372904682018 @default.
• W2337290468 countsByYear W23372904682019 @default.
• W2337290468 countsByYear W23372904682020 @default.
• W2337290468 countsByYear W23372904682021 @default.
• W2337290468 countsByYear W23372904682022 @default.
• W2337290468 countsByYear W23372904682023 @default.
• W2337290468 crossrefType "journal-article" @default.
• W2337290468 hasAuthorship W2337290468A5049615226 @default.
• W2337290468 hasAuthorship W2337290468A5056108298 @default.
• W2337290468 hasAuthorship W2337290468A5059475095 @default.
• W2337290468 hasAuthorship W2337290468A5080954009 @default.
• W2337290468 hasBestOaLocation W23372904681 @default.
• W2337290468 hasConcept C104317684 @default.
• W2337290468 hasConcept C126322002 @default.
• W2337290468 hasConcept C141071460 @default.
• W2337290468 hasConcept C159654299 @default.
• W2337290468 hasConcept C185592680 @default.
• W2337290468 hasConcept C197934379 @default.
• W2337290468 hasConcept C203014093 @default.
• W2337290468 hasConcept C2778961111 @default.
• W2337290468 hasConcept C2781221834 @default.
• W2337290468 hasConcept C2992139802 @default.
• W2337290468 hasConcept C32611913 @default.
• W2337290468 hasConcept C40767141 @default.
• W2337290468 hasConcept C55493867 @default.
• W2337290468 hasConcept C71924100 @default.
• W2337290468 hasConcept C90924648 @default.
• W2337290468 hasConceptScore W2337290468C104317684 @default.
• W2337290468 hasConceptScore W2337290468C126322002 @default.
• W2337290468 hasConceptScore W2337290468C141071460 @default.
• W2337290468 hasConceptScore W2337290468C159654299 @default.
• W2337290468 hasConceptScore W2337290468C185592680 @default.
• W2337290468 hasConceptScore W2337290468C197934379 @default.
• W2337290468 hasConceptScore W2337290468C203014093 @default.
• W2337290468 hasConceptScore W2337290468C2778961111 @default.
• W2337290468 hasConceptScore W2337290468C2781221834 @default.
• W2337290468 hasConceptScore W2337290468C2992139802 @default.
• W2337290468 hasConceptScore W2337290468C32611913 @default.
• W2337290468 hasConceptScore W2337290468C40767141 @default.
• W2337290468 hasConceptScore W2337290468C55493867 @default.
• W2337290468 hasConceptScore W2337290468C71924100 @default.
• W2337290468 hasConceptScore W2337290468C90924648 @default.
• W2337290468 hasIssue "7" @default.
• W2337290468 hasLocation W23372904681 @default.
• W2337290468 hasLocation W23372904682 @default.
• W2337290468 hasOpenAccess W2337290468 @default.
• W2337290468 hasPrimaryLocation W23372904681 @default.
• W2337290468 hasRelatedWork W202066583 @default.
• W2337290468 hasRelatedWork W2033795470 @default.
• W2337290468 hasRelatedWork W2058976806 @default.
• W2337290468 hasRelatedWork W2079472156 @default.
• W2337290468 hasRelatedWork W2298132123 @default.

• next